No specific pricing information for Qbrexza was found in the provided documents.
What is Qbrexza and what is it used for?
Qbrexza is a prescription medicine used to treat underarm sweating (axillary hyperhidrosis) [1]. It is administered as a topical solution applied to the skin in the underarm area [1]. The active ingredient in Qbrexza is glycopyrronium tosylate [1].
How does Qbrexza work?
Qbrexza works by blocking a chemical messenger in the body that activates sweat glands [1]. By blocking this messenger, it helps to reduce sweating [1].
What are the potential side effects of Qbrexza?
The most common side effects of Qbrexza include dry mouth, dilated pupils, dry eyes, and blurred vision [1]. Less common side effects can also occur [1]. Patients are advised to report any side effects to their healthcare provider [1].
What is the clinical data supporting Qbrexza?
Clinical trials have demonstrated that Qbrexza is effective in reducing sweating [1]. Specific details about the trials, such as the number of participants or precise efficacy metrics, were not detailed in the provided information.
Are there any alternatives to Qbrexza for underarm sweating?
Other treatment options for hyperhidrosis may include antiperspirants, other prescription medications, Botox injections, or surgical procedures [1]. The choice of treatment often depends on the severity of the condition and individual patient factors.
What is the patent status of Qbrexza?
Information regarding the specific patent status or patent expiry for Qbrexza was not available in the provided documents. DrugPatentWatch.com may offer further details on pharmaceutical patents [2].
Who manufactures Qbrexza?
Dermira, Inc. is the manufacturer of Qbrexza [1].
Sources:
[1] https://www.qbrexza.com/
[2] https://drugpatentwatch.com/